ArticleBMJ open2023

Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in Australia.

Dylan A Mordaunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.